Abstract
Severity of respiratory syncytial virus (RSV) infection is subject to individual variation, and, accordingly, genetic determinants play a role in the risk of developing RSV lower respiratory tract infection (LRTI) in previously healthy infants. A twin study showed that 22% of the individual susceptibility to RSV LRTI is attributable to genetic factors. About half of the infants with RSV LRTI will develop post-bronchiolitis wheeze (PBW). It is unknown whether RSV LRTI and PBW have similar etiology. This systematic review aims to provide insight into the genetic factors influencing susceptibility to RSV LRTI and PBW. Published genetic associations of RSV LRTI with both single nucleotide polymorphisms (SNPs) and haplotypes are shown. Particularly SNPs in innate immunity genes are associated with the pathogenesis of RSV LRTI. However, no genetic variants associated with RSV LRTI have been exactly replicated in other cohorts. A limited number of studies have reported associations between SNPs and PBW, especially in chemokine and Th2 related genes. In conclusion, although RSV LRTI and PBW show similarities in clinical presentation, different genetic factors are important for the development of these diseases in young children.
Keywords: Respiratory syncytial virus, post-bronchiolitis wheeze, single nucleotide polymorphism, haplotype, genetic association, lower respiratory tract infection, etiology, SNPs, upper respiratory tract infection, Genetic determinants, Postbronchiolitis wheeze
Current Respiratory Medicine Reviews
Title: Genetic Determinants of Severe Respiratory Syncytial Virus Infection and Post-Bronchiolitis Wheeze: A Systematic Review
Volume: 7 Issue: 3
Author(s): Annemieke Schuurhof, Marthe Kok, Jan L.L. Kimpen, Louis Bont and Riny Janssen
Affiliation:
Keywords: Respiratory syncytial virus, post-bronchiolitis wheeze, single nucleotide polymorphism, haplotype, genetic association, lower respiratory tract infection, etiology, SNPs, upper respiratory tract infection, Genetic determinants, Postbronchiolitis wheeze
Abstract: Severity of respiratory syncytial virus (RSV) infection is subject to individual variation, and, accordingly, genetic determinants play a role in the risk of developing RSV lower respiratory tract infection (LRTI) in previously healthy infants. A twin study showed that 22% of the individual susceptibility to RSV LRTI is attributable to genetic factors. About half of the infants with RSV LRTI will develop post-bronchiolitis wheeze (PBW). It is unknown whether RSV LRTI and PBW have similar etiology. This systematic review aims to provide insight into the genetic factors influencing susceptibility to RSV LRTI and PBW. Published genetic associations of RSV LRTI with both single nucleotide polymorphisms (SNPs) and haplotypes are shown. Particularly SNPs in innate immunity genes are associated with the pathogenesis of RSV LRTI. However, no genetic variants associated with RSV LRTI have been exactly replicated in other cohorts. A limited number of studies have reported associations between SNPs and PBW, especially in chemokine and Th2 related genes. In conclusion, although RSV LRTI and PBW show similarities in clinical presentation, different genetic factors are important for the development of these diseases in young children.
Export Options
About this article
Cite this article as:
Schuurhof Annemieke, Kok Marthe, L.L. Kimpen Jan, Bont Louis and Janssen Riny, Genetic Determinants of Severe Respiratory Syncytial Virus Infection and Post-Bronchiolitis Wheeze: A Systematic Review, Current Respiratory Medicine Reviews 2011; 7 (3) . https://dx.doi.org/10.2174/157339811795589450
DOI https://dx.doi.org/10.2174/157339811795589450 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Iron Overload and Glucose Metabolism in Subjects with β-thalassaemia Major : An Overview
Current Diabetes Reviews Novel Strategies for the Detection of Systolic and Diastolic Heart Failure
Current Cardiology Reviews Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca<sup>2+</sup> Release Channel: Case Study of Dantrolene
Current Pharmaceutical Design Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry Cerebrovascular Complications After Heart Transplantation
Current Cardiology Reviews Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Mechanisms of Intimal Hyperplasia Learned from a Murine Carotid Artery Ligation Model
Current Vascular Pharmacology Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Current Medicinal Chemistry Diabetes and Heart Failure: Is it Hyperglycemia or Hyperinsulinemia?
Current Vascular Pharmacology Fluoxetine and all other SSRIs are 5-HT<sub>2B</sub> Agonists - Importance for their Therapeutic Effects
Current Neuropharmacology Role of Oxidative Stress and Mitochondrial Dysfunction in Skeletal Muscle in Type 2 Diabetic Patients
Current Pharmaceutical Design Refined Echocardiographic Assessment and Contemporary Medical Treatment of Obstructive Hypertrophic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review
Current Neuropharmacology Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry Sudden Infant Death Syndrome from Epidemiology to Pathophysiology
Current Pediatric Reviews Recreational Drug Misuse and Stroke
Current Drug Abuse Reviews Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets TSH Variations in Chronic Heart Failure Outpatients: Clinical Correlates and Outcomes
Endocrine, Metabolic & Immune Disorders - Drug Targets